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Abstract
Background: Periodontal inflammation is characterized by injuries in collagen, epithelial, bone tissues. The hypotheses
to be tested were relationship between the s100, bcl2 and myeloperoxidase in gingival tissues (MPO does affect the
level of s100, bcl2). The object of this study was to investigate of s100 expression, bcl2 expression and myeloperoxidase
expression in periodontal inflammation.
Methods: 27 patients (giant-cell epulis) and 30 patients (acute and chronic inflammations) were included in the
study for s100 expression, bcl2 expression and myeloperoxidase expression by immunohistochemistry and
hematoxylin - eosin.
Results: Giant-cells in epulis positivity for myeloperoxidase has been observed in 100 % However, only 75.31 % of
giant-cells were positive for bcl2 expression. Acute 98.2 %, and chronic 89.28 % inflammation was a significant positive
for myeloperoxidase. The immunohistochemical findings of s100, bcl 2 and myeloperoxidase in epithelial layers have
showed the result of 100 %, 82,2 %, 100 % positive cells in acute and 100 %, 78.25 %, 100 % in chronic process of
inflammation respectively.
Conclusion: The results indicate that the pathogenesis of periodontal inflammation might involve inhibition of cell
death, through the overexpression of bcl-2, due to identifying factors myeloperoxidase (result in the DNA damage by
the product of catalysis). The highest levels of s100 activity have been found at sites with chronic inflammation.
Background
Bacterial infections are the most important etiologic
agents involved in acute and chronic periodontitis, it is
multifactorial disease that leads to the destruction of the
bone periodontium [1]. Inflammatory cells infiltration
has been resulted from periodontal plasma cells: neutro-
phil, T- & B- lymphocytes and macrophages [2]. Peri-
odontal lesions have been characterized by a persistence
of infiltrating inflammatory cells, which may be respon-
sible for the bone collagens resorcinol. Research by
Baelum V. & Lopez R. [3] demonstrated that periodontal
disease affects between 10 % and 15 % of the world’s
population, being the greatest cause of tooth loss.
Inflammatory cells (plasma cells) have expressed in
myeloperoxidase. Polymorphonuclear neutrophils are
largely expressed the myeloperoxidase in plasma cells [4].
The myeloperoxidase gene is located on chromosome 17
(17q23.1) [5].
Myeloperoxidase (MPO) have catalyzed the synthesis
of microbicidal hypochlorous acid enabling the defence
against bacteria [6]. Furthermore, plasma cells synthesize
hypochlorous acid from H2O2 and NaCl. Hydroxyl
radical (−OH) is mostly active in damaging important
molecules such as DNA proteins and lipids [7]. Hydro-
gen peroxide (H2O2) being a potent agent of oxygen
species, is capable of crossing the nuclear membrane
and damaging the DNA. [8] There is growing support
for the claim that inflammation induces DNA damage
which leads to apoptosis in periodontal cells [9] Fur-
thermore, the apoptotic stimuli can trigger apoptosis
via different mechanisms, including specific cell death
receptors and ligands, such as cd95 [10], stress signals,
inducing molecules directly or indirectly in apoptosis,
via p53. Bcl2 is a member of anti-apoptotic family
proteins that can prevent or reduce cell death induced
by a variety of stimuli [11]. The BCL-2 gene was identi-
fied in the chromosome human t(14;18) [12]. The in-
trinsic death pathway is initiated by the mitochondrial* Correspondence: kuzenko_yevhen@rambler.ru
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release of cytochrome c, a process that is inhibited by
anti-apoptotic bcl2 proteins [13].
S100 proteins have expressed in the neutrophils cytosol,
monocytes, activated macrophages, and keratinocytes and
released during activation or death of these cells. The
S100 gene family includes at least 13 members that locate
as a cluster on chromosome 1q21 [14]. s100 proteins also
known as L1 antigens, calgranulin A and B, macrophage
migration inhibitory, factor-related protein (MRP) and
cystic fibrosis antigen, have several functions in inflamma-
tory reactions [15].
The results by Sun-Hee Heo et. al. [16] have shown the
expression patterns of S100A2 in gingival tissues during
bacterial lipopolysaccharide stimulation. S100A2 expres-
sion was upregulated by bacterial lipopolysaccharide.
We have hypothesis states that there is the relation-
ship between the s100, bcl2 and myeloperoxidase in
gingival tissues (MPO does affect the level of s100,
bcl2).
The aim of this study is to compare the expression
levels of s100, bcl2 and MPO in gingival tissues on dif-
ferent stages of periodontal disease and compared to
the giant-cell epulis.
Methods
Patient selection and of gingival tissues collection
The study samples have included the periodontal and
epulis tissues of the patients. The subjects were divided
into two equal groups:
Patient Group (Group 1). Giant cell granuloma speci-
mens were collected from 27 people who had a morpho-
logically diagnosis of giant cell granuloma (eight males
and 14 females, age range 30 to 70 years, mean age, 47,51
± 12.37 years).
Control group (Group 2) consisted of 30 patients who
had died in Sumy Regional Hospital. The patients had
various somatic diagnoses (not atherosclerotic complica-
tions) and dental – parodontit. 17 males and 13 females,
age range 43 to 69 years, mean age, 57.33 ± 8.31 years
have been investigating. The specimens of overgrown
gingiva were collected during jaws sawing procedures.
After group 2 tissue samples stained by hematoxylin
eosin foo, all samples were divided in two groups (acute
and chronic). Control group has two subgroups. Acute
subgroups - 13 (5 males and 3 females, age range 43 to
69 years, mean age, 54.38 ± 7.9 years). Chronic sub-
groups - 17 (7 males and 15 females, age range 44 to
68 years, mean age, 59.58 ± 8.11 years).
Informed written consent was obtained from all study
subjects in accordance with guidelines established by
the Ukraine Health Council. The present study was
approved by the Sumy State University (Protocol no. 5/
2012).
Hematoxylin and eosin (H&E)
Stains have been used for at least a century and are still
essential for identifying various tissue types and the
morphologic change.
Immunostainings
For s100, bcl2 and MPO have been performed formalin-
fixed (pH 7,4) tissue. Paraffin-embedded tissue sections
have been treated dy mouse monoclonal anti-s100, anti-
bcl2 and anti-myeloperoxidase (Thermo Fisher Scientific
UK). Briefly, 4 μm thick tissue sections were dewaxed in
xylene and were placed in to water through graded alco-
hols. Antigen retrieval has been performed by microwav-
ing slides in 10 mM citrate buffer (pH 6.2) for 30 min at
high power, according to the manufacturer’s instructions.
To remove the endogenous peroxidase activity, the
sections have been treated with freshly prepared 1.0 %
hydrogen peroxide in the dark for 30 min at 37 °C
temperature. Non-specific antibody binding was blocked
by means of blocking serum. The sections were incu-
bated for 30 min, at 37 °C temperature, with the primary
antibodies against s100, bcl2 and myeloperoxidase
diluted 1:100 in phosphate buffered saline (PBS) pH 7.2
then a triple washing with PBS follows. Anti-(mouse
IgG)–horseradish peroxidase conjugate (1:40 000 dilution)
has been fulfilled for the detection of the S100, Bcl2 and
MPO primariy antibodies, then the sections were incu-
bated for 20 min, at 37 °C temperature. The colour was
visualized by DAB.
The appearance of the positive factors was detected
semiquantitatively by counting of positive giant cells in
visual field.
The data were analysed using STATISTICA 8.0 soft-
ware, user version STA862D175437Q. The results have
been presented as mean ± SD. The normalize test have
been use before analysis of the data. Also, the non-
parametric Student method was applied to perform a
simple comparative analysis. The value of P < 0.05 have
been considered to be a significant.
Results
The groups 1 and 2 of men and women consisted mostly
age range 30- to 70-years. Group 1 giant cells occurred
in the lower jaw (55 %) more frequently than in the
upper jaw. In the group 2 the patients have been divided
into 13 with acute and 17 with chronic inflammations.
In Fig. 1a A we observed low-size cell infiltration in
acute inflammation. Significant cell infiltration and pro-
liferating epithelium (Fig. 1b) appeared to be more in-
tensive in the chronic inflammation. Acute and chronic
inflammatory cells are circulating leukocytes, plasma
cells and tissue macrophages.
Peripheral giant cell epulis is shown in Fig. 1c Micro-
scopic examination has revealed the tissue with the
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abundance of giant-cells (Fig. 1c F), fibrous connective
tissue, areas of haemorrhages (Fig. 1c E) and few capil-
laries. There was no sign of malignancy. Chronic in-
flammation when the macrophages fail to disintegrated
various particles, fuse together and form multinucleated
giant cells. Besides, morphologically distinct giant cells
also appear in some tumours also.
S100, Bcl2 and MPO expressed in giant-cells. S100
expression, bcl2 expression and myeloperoxidase ex-
pression in giant-cells epulis are shown in Fig. 2. By im-
munohistochemistry, 100 % of giant-cells appeared to
be positive for myeloperoxidase, whereas only 75,31 %
of giant-cells were positive for Bcl 2 (P < 0.05). By the
fact s100 protein has expressed in 10,72 % of giant-cells.
Myeloperoxidase has physiologically expressed in plas-
matic cells of epulis 87,69 %. s100 and bcl 2 have
expressed in plasmatic cells 24,34 % (P < 0.05) and
11,28 % respectively, bcl 2 and myeloperoxidase ex-
pression being weak or absent in the connective tissue.
The immunoexpression of s100, bcl2 end MPO (Group
2) have been confirmed by the presence of brown stained
cytoplasm in cell infiltration. In general, s100 staining was
more intensive in the plasmatic cells. In acute inflamation
S100 (Fig. 2) only 36,2 ± 5,3 % of the cells appeared to be
positive. The cell infiltration, showed bcl2 immunoreactiv-
ity figured 76,1 ± 3,3 % (P < 0.05) in acute process (Fig. 2).
Myeloperoxidase has expressed in 98,2 ± 5,9 % (P < 0.01)
positive cells in acute inflammation.
Figure 2 shows the results of the s100, bcl2 and MPO
expression in chronic process.
Myeloperoxidase 82,28 ± 2,5 % P < 0.01 was expressed
in chronic plasmatic cell infiltration during inflamma-
tion. Bcl 2 was expressed in chronic plasmatic cells
infiltration 55,67 ± 6,1 % P < 0.05. Тhe immunoexpres-
sion of S100 in cell infiltration has shown the result of
95,0 ± 0.31 % positive cells.
Тhe immunoexpression of s100, bcl2 and MPO in
epithelial layers (acute process) have shown the result of
100 %, 82,2 ± 2.93 % and 100 % respectively. In chronic
process of inflammation the positive cells have demon-
stratrd s100 - 100 %, bcl2 – 78,25 ± 4,23 % and myeloper-
oxidase - 100 % respectively.
Discussion
This study has claimed that MPO was able to stimulate
higher of bcl2 expression in inflammation cells during
chronic and acute process. Myeloperoxidase activity
expressed in neutrophils recruited to the gingiva after
chemical or immunological insults contributes to tissue
destruction. Meloperoxidase might influence the extent
and/or the severity of periodontal diseases [17].
High level of the MPO have been observed in giant
cells. Elevated bcl2 expression levels can prevent cellular
apoptosis, thereby inducing inflammatory cells to remain
locally in the periodontal tissue, causing consequent ex-
cessive cytokine secretion which leads to the progressive
destruction of periodontal tissues [1]. Myeloperoxidase
can be liberated from activated neutrophils by degranu-
lation only in moderate levels [18], and bcl2 availability
protects regions. Cytolysis of neutrophils in the course
Fig 1 The periodontal tissues Haematoxylin and Eosin stained (x100 magnification) A (a) – pint-size cells infiltration with superimposed edema, B (a) – layers
of the epithelium, C (b) - great cells infiltration with superimposed edema, D (a) – epithelial proliferation, E (c) - hemorrhage zone, F (c) - Giant cells
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Fig 3 S100, bcl2 and myeloperoxid protein interaction during periodontal inflammation
Fig 2 Expression of s100, bcl2and myeloperoxidase in gingival tissue (x100 magnification): A – Layers of the epithelium with myeloperoxidase
expression, B – Blood cells infiltration with myeloperoxidase expression, C – Pericellular and perivascular edema, D – Blood cells infiltration with
myeloperoxidase expression, E – Layers of the epithelium with myeloperoxidase expression and proliferation, F – Giant cells with
myeloperoxidase expression, G – Fibroblastic stroma, H – Blood cells infiltration with myeloperoxidase expression, I – Pericellular and perivascular
edema, G – Blood cells infiltration with Bcl 2expression, K – Layers of the epithelium with high level of bcl 2 expression, L – Layers of the
epithelium with bcl 2expression, N – Fibroblastic stroma, M – Blood cells infiltration with bcl 2 expression, O – Pericellular and perivascular
edema, P – Giant cells with bcl 2 expression, Q – Blood cells infiltration with low bcl 2expression, R – Blood cells infiltration with s100 expression,
S – Pericellular and perivascular edema, T – Layers of the epithelium with s100 expression, U – Layers of the epithelium with low s100 expression,
V – Fibroblastic stroma, W – Blood cells infiltration with s100 expression, X – Fibroblastic stroma, Y – Giant cells with “poor” s100 expression
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of inflammation formation could provide a release mech-
anism [18, 19] and explain the high levels of myeloperoxi-
dase and S100. Activity of S100A12 and C-reactive
protein can be markers of inflammatory activity in chronic
periodontitis [20]. Previous studies have suggested that
apoptosis is involved in the pathogenesis of inflammatory
periodontal disease [21]. It has also been demonstrated
that the higher frequency of Bcl-2 expression results in
progressive periodontal destruction [22].
Gamonall et all. [23] has not found statistical differ-
ence in varions amount of bcl2 in healthy gingiva and
in gingiva of patients with periodontal disease. Our
studies have confirmed the view of Pandilova [24] and
Ellis et all. [25] that chronic progression of inflamma-
tion decrease expresses bcl-2. In human gingival fibro-
blasts with inflammation activation of bcl2 has not
been observed in different stages of the infection and
giant-cell epulis. Sule Bulut et all. [26] results indicate
that the pathogenesis of cyclosporin A induced gingival
overgrowth might involve inhibition of apoptosis and
overexpression of bcl-2 in the setting of high serum
cyclosporin A. Our study has demonstrated a high level
of bcl2 expression and inhibition of apoptosis in cells
of gingival epithelium. We believe this is due to the epi-
thelium protective functions. In gingival epithelium
s100 is also related to the differentiation stage [27].
These positive cells are known to activate macrophages
or neutrophils [28]. Research by Saito et al. [29] dem-
onstrated numerous bcl-2-positive epithelial cells in
gingival biopsies from patients who were taking nifedi-
pine and phenytoin, indicating that this protein might
be involved in the development of nifedipine-induced
gingival hyperplasia. We believe that the presence of
Bcl-2 protein is not an indicator of giant cell epulis
favorable courses.
S100 plays a important part in the immune response
related to periodontitis. s100 binds 2 Ca2+ and 2 Zn2+
ions. If Zn2+ binds to S100 it decreases its Ca2+ affinity.
S100 also interacts with p53 in a Ca2 + −dependent
manner, which affects stability of S100-p53 interaction
[30] Aforesaid s100-p53 interaction leads to inhibition of
apoptosis during inflammation. The Bcl-2 protein is a
potent inhibitor of cell death, whereas the wild-type p53
protein activates the apoptotic pathway [5].
Mutated p53 loses this function and allows the pro-
liferation of neoplastic cells. Bcl-2 also modulates the
function of p53 and triggers cell proliferation and
transformation [31].
Thr expression of S100 have been detected as proinflam-
matory phagocytes cells at sites of intestinal inflammation
[32, 33]. Systemic autoimmune diseases (dermatomyositis,
systemic lupus erythematosus, Kawasaki disease etc.) have
clear association with S100 expression in macrophages
infiltraton with degeneration of tissue [34, 35].
Conclusion
Investigations on bcl2 marker in gingival cells during
periodontal inflammation we suggestion that periodon-
tium tissues, continuously exposed to bacterial infections
may contain cells with high level of myeloperoxidase
results that damage DNA by product of catalysis.
The highest levels of s100 activity have been found at
sites with chronic inflammation. Our results suggest that
low s100 expression may play an important role in the
activity of giant cells in giant cell epulis. That is consid-
ered to be the most significant factors of prognosis in
giant cell granuloma. As a result of our research we
created a diagram Fig. 3.
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